# Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT

> **NCT05277454** · PHASE1 · UNKNOWN · sponsor: **Hutchison Medipharma Limited** · enrollment: 113 (estimated)

## Conditions studied

- Advanced Malignant Solid Tumors
- TGCT

## Interventions

- **DRUG:** HMPL-653

## Key facts

- **NCT ID:** NCT05277454
- **Lead sponsor:** Hutchison Medipharma Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-18
- **Primary completion:** 2024-06-28
- **Final completion:** 2025-04-14
- **Target enrollment:** 113 (ESTIMATED)
- **Last updated:** 2022-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05277454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05277454, "Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05277454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*